Fukuchi M - Search Results

1

Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma.

Miyazaki T, Kato H, Faried A, Sohda M, Nakajima M, Fukai Y, Masuda N, Manda R, Fukuchi M, Ojima H, Tsukada K, Kuwano H. Miyazaki T, et al. Among authors: fukuchi m. Anticancer Res. 2005 Jul-Aug;25(4):2749-55. Anticancer Res. 2005. PMID: 16080521 Free article. Clinical Trial.

2

Decreased Smad4 expression in the transforming growth factor-beta signaling pathway during progression of esophageal squamous cell carcinoma.

Fukuchi M, Masuda N, Miyazaki T, Nakajima M, Osawa H, Kato H, Kuwano H. Fukuchi M, et al. Cancer. 2002 Aug 15;95(4):737-43. doi: 10.1002/cncr.10727. Cancer. 2002. PMID: 12209716 Free article.

3

Usefulness of positron emission tomography for assessing the response of neoadjuvant chemoradiotherapy in patients with esophageal cancer.

Kato H, Kuwano H, Nakajima M, Miyazaki T, Yoshikawa M, Masuda N, Fukuchi M, Manda R, Tsukada K, Oriuchi N, Endo K. Kato H, et al. Among authors: fukuchi m. Am J Surg. 2002 Sep;184(3):279-83. doi: 10.1016/s0002-9610(02)00932-7. Am J Surg. 2002. PMID: 12354600

4

EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma.

Miyazaki T, Kato H, Fukuchi M, Nakajima M, Kuwano H. Miyazaki T, et al. Among authors: fukuchi m. Int J Cancer. 2003 Feb 20;103(5):657-63. doi: 10.1002/ijc.10860. Int J Cancer. 2003. PMID: 12494475

5

High-level expression of the Smad ubiquitin ligase Smurf2 correlates with poor prognosis in patients with esophageal squamous cell carcinoma.

Fukuchi M, Fukai Y, Masuda N, Miyazaki T, Nakajima M, Sohda M, Manda R, Tsukada K, Kato H, Kuwano H. Fukuchi M, et al. Cancer Res. 2002 Dec 15;62(24):7162-5. Cancer Res. 2002. PMID: 12499250

6

Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness.

Kato H, Takita J, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Kuwano H. Kato H, et al. Among authors: fukuchi m. Anticancer Res. 2002 Sep-Oct;22(5):2635-9. Anticancer Res. 2002. PMID: 12529975

7

Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.

Kato H, Yoshikawa M, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Tsukada K, Kuwano H. Kato H, et al. Among authors: fukuchi m. Anticancer Res. 2002 Nov-Dec;22(6C):3977-84. Anticancer Res. 2002. PMID: 12553021

8

Reduced expression of transforming growth factor-beta receptors is an unfavorable prognostic factor in human esophageal squamous cell carcinoma.

Fukai Y, Fukuchi M, Masuda N, Osawa H, Kato H, Nakajima T, Kuwano H. Fukai Y, et al. Among authors: fukuchi m. Int J Cancer. 2003 Mar 20;104(2):161-6. doi: 10.1002/ijc.10929. Int J Cancer. 2003. PMID: 12569570

9

Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma.

Kato H, Takita J, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Kuwano H, Oriuchi N, Endo K. Kato H, et al. Among authors: fukuchi m. Anticancer Res. 2003 Jul-Aug;23(4):3263-72. Anticancer Res. 2003. PMID: 12926062

10

Efficacy and toxicity of nedaplatin and 5-FU with radiation treatment for advanced esophageal carcinomas.

Kato H, Fukuchi M, Manda R, Nakajima M, Miyazaki T, Sohda M, Masuda N, Fukai Y, Tsukada K, Kuwano H. Kato H, et al. Among authors: fukuchi m. Anticancer Res. 2003 Jul-Aug;23(4):3493-8. Anticancer Res. 2003. PMID: 12926096 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

489 results

Search Page

Filters